Choice of treatment and adherence to international ESO-ESMO (ABC) guidelines in HR+/HER2-ve metastatic breast cancer (MBC) patients (pts).
Marina Elena Cazzaniga(Azienda Ospedaliera San Gerardo), Ornella Garrone(Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo), Filippo Montemurro(Roche (Switzerland)), Vincenzo Graziano(University of Chieti-Pescara), Giorgio Mustacchi(University of Trieste), P. Pronzato(Accademia Nazionale dei Lincei), Claudia De Angelis(University of Naples Federico II), Alessandra Beano(Presidio Ospedaliero), Lorenzo Livi(European Society for Sexual Medicine), Laura Biganzoli(Hospital of Prato), Paola Caporello(Sapienza University of Rome), Anna Turletti(Ospedale Martini), Lucia Del Mastro(Ospedale Policlinico San Martino), Sabino De Placido, Ferdinando Riccardi(Ospedale Antonio Cardarelli), Emanuela Romagnoli(Medica (Italy))
Cited by 1
Related Papers
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k
4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
|Annals of Oncology|2018|1.2k